HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.K. Ad Watchdog Splits Hairs With Alberto Over TRESemme Naturals Ads

This article was originally published in The Rose Sheet

Executive Summary

Alberto-Culver is advised to discontinue TV and print ads for its TRESemme Naturals shampoo and conditioner because it failed to substantiate a claim that the products make hair “10x stronger.”

You may also be interested in...

NACDS Marketplace In Brief

L'Oreal: Revitalift Deep-Set Wrinkle Repair 24 HR Eye Duo delivers continuous, 24-hour repair to skin around eyes, L'Oreal announces during National Association of Chain Drug Stores Marketplace conference June 28-July 1. The cream contains Pro-Retinol A to repair skin fibers and smooth out deep-set eye wrinkles, firm says. Launching now for around $19.99, the product is promoted in ads featuring spokeswoman Andie MacDowell. L'Oreal Extra Volume Collagene mascara is shipping now as well. Product's big brush and hydro-collagen-enriched formula produce dramatic lashes. Spokesperson Eva Longoria is appearing in ads for the mascara, which include the claim that the product delivers "12x more impact instantly.

FTC Commissioner Proposes Making Endorsement Guides Into Rules, Seeking Stiffer Penalties

At least one FTC commissioner seems convinced that the agency’s Enforcement Guides are ripe for an update to address unscrupulous influencer marketing practices. Democrat Rohit Chopra proposes their codification into formal rules that would make violators liable for civil penalties and damages under FTC Act provisions.

Ohio Study Shows Access To Naloxone Soars Without Rx Requirement

JAMA study finds that removing Rx requirement for naloxone in Ohio resulted in a 2,328% increase in orders of the drug dispensed since 2015. Michael Hufford, CEO of a company working on an OTC switch for a naloxone nasal spray, says the results show urgent need for a low-cost OTC product.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts